Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_assertion description "[Applying a next-generation sequencing assay targeting 145 cancer-relevant genes in 40 colorectal cancer and 24 non-small cell lung cancer formalin-fixed paraffin-embedded tissue specimens identified at least one clinically relevant genomic alteration in 59% of the samples and revealed two gene fusions, C2orf44-ALK in a colorectal cancer sample and KIF5B-RET in a lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_assertion evidence source_evidence_literature NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_assertion SIO_000772 22327622 NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_assertion wasDerivedFrom befree-20150227 NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_assertion wasGeneratedBy ECO_0000203 NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.
- befree-20150227 importedOn "2015-02-27" NP524246.RAkUO4nxQE0fX7flumar7XqHoBu5lQaT2SVPwvmz5C768130_provenance.